Research ArticleRheumatoid Arthritis

The Prevalence of Rheumatoid Arthritis in Chile: A Nationwide Study Performed as Part of the National Health Survey

Josefina Durán, Loreto Massardo, Carolina Llanos, Sergio Iacobelli, Paula I. Burgos, Marcela Cisternas, Mirentxu Iruretagoyena, Macarena Armstrong, Raquel Aguilera, Francisco Radrigán, María Eugenia Martinez, Alvaro Passi-Solar, Pablo Riedemann, Natalia Crisóstomo, Camila Cifuentes, Lucero Hagedorn, Alvaro Cisternas, Nancy Vasquez, Paula Margozzini and the ENS2017 Study Group
The Journal of Rheumatology July 2020, 47 (7) 951-958; DOI: https://doi.org/10.3899/jrheum.190396

REFERENCES

  1. 1.↵
    1. Allaire S,
    2. Wolfe F,
    3. Niu J,
    4. LaValley MP
    . Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US. Arthritis Rheum 2008;59:474–80.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Chorus AM,
    2. Miedema HS,
    3. Boonen A,
    4. Van Der Linden S
    . Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 2003;62:1178–84.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Strand V,
    2. Khanna D
    . The impact of rheumatoid arthritis and treatment on patients’ lives. Clin Exp Rheumatol 2010;3 Suppl 59:S32–40.
    OpenUrl
  4. 4.↵
    1. Verstappen SM,
    2. Bijlsma JW,
    3. Verkleij H,
    4. Buskens E,
    5. Blaauw AA,
    6. ter Borg EJ,
    7. et al.
    Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Care Res 2004;51;488–97.
    OpenUrlCrossRef
  5. 5.↵
    1. Minnock P,
    2. Fitzgerald O,
    3. Bresnihan B
    . Quality of life, social support, and knowledge of disease in women with rheumatoid arthritis. Arthritis Rheum 2003;49:221–7.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Clarke AE,
    2. Zowall H,
    3. Levinton C,
    4. Assimakopoulos H,
    5. Sibley JT,
    6. Haga M,
    7. et al.
    Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study. J Rheumatol 1997;24:1051–60.
    OpenUrlPubMed
  7. 7.↵
    1. Michaud K,
    2. Messer J,
    3. Choi HK,
    4. Wolfe F
    . Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients. Arthritis Rheum 2003;48:2750–62.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. McBride S,
    2. Sarsour K,
    3. White LA,
    4. Nelson DR,
    5. Chawla AJ,
    6. Johnston JA
    . Biologic disease-modifying drug treatment patterns and associated costs for patients with rheumatoid arthritis. J Rheumatol 2011;38:2141–9.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Alamanos Y,
    2. Voulgari PV,
    3. Drosos AA
    . Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006;36:182–8.
    OpenUrlCrossRefPubMed
  10. 10.
    1. Simonsson M,
    2. Bergman S,
    3. Jacobsson LT,
    4. Petersson IF,
    5. Svensson B
    . The prevalence of rheumatoid arthritis in Sweden. Scand J Rheumatol 1999;28:340–3.
    OpenUrlCrossRefPubMed
  11. 11.
    1. Guillemin F,
    2. Saraux A,
    3. Guggenbuhl P,
    4. Roux CH,
    5. Fardellone P,
    6. Le Bihan E,
    7. et al.
    Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis 2005;64:1427–30.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. MacGregor AJ,
    2. Riste LK,
    3. Hazes JM,
    4. Silman AJ
    . Low prevalence of rheumatoid arthritis in black-Caribbeans compared with whites in inner city Manchester. Ann Rheum Dis 1994;53:293–7.
    OpenUrlAbstract/FREE Full Text
  13. 13.
    1. Rasch EK,
    2. Hirsch R,
    3. Paulose-Ram R,
    4. Hochberg MC
    . Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum 2003;48:917–26.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Carmona L,
    2. Villaverde C,
    3. Hernandez-García C,
    4. Ballina J,
    5. Gabriel R,
    6. Laffon A;
    7. EPISER Study Group
    . The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology 2002;41:88–95.
    OpenUrlCrossRefPubMed
  15. 15.
    1. Peláez-Ballestas I,
    2. Sanin LH,
    3. Moreno-Montoya J,
    4. Alvarez-Nemegyei J,
    5. Burgos-Vargas R,
    6. Garza-Elizondo M,
    7. et al;
    8. Grupo de Estudio Epidemiológico de Enfermedades Músculo Articulares (GEEMA)
    . Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol Suppl. 2011 Jan;86:3–8.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Guevara-Pacheco S,
    2. Feicán-Alvarado A,
    3. Sanín LH,
    4. Vintimilla-Ugalde J,
    5. Vintimilla-Moscoso F,
    6. Delgado-Pauta J,
    7. et al.
    Prevalence of musculoskeletal disorders and rheumatic diseases in Cuenca, Ecuador: a WHO-ILAR COPCORD study. Rheumatol Int 2016;36:1195–204.
    OpenUrl
  17. 17.↵
    1. Senna ER,
    2. De Barros AL,
    3. Silva EO,
    4. Costa IF,
    5. Pereira LV,
    6. Ciconelli RM,
    7. et al.
    Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 2004;31:594–7.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Spindler A,
    2. Bellomio V,
    3. Berman A,
    4. Lucero E,
    5. Baigorria M,
    6. Paz S,
    7. et al.
    Prevalence of rheumatoid arthritis in Tucumán, Argentina. J Rheumatol 2002;29:1166–70.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Riedemann JP,
    2. Maluje V
    . [Epidemiology of rheumatic diseases in Chile]. [Article in Spanish] Proyecto Fondecyt 1930390, 1993 [Chilean National Archives].
  20. 20.↵
    1. Eyheramendy S,
    2. Martinez FI,
    3. Manevy F,
    4. Vial C,
    5. Repetto GM
    . Genetic structure characterization of Chileans reflects historical immigration patterns. Nat Commun 2015;6:6472.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Bennett K,
    2. Cardiel MH,
    3. Ferraz MB,
    4. Riedemann P,
    5. Goldsmith CH,
    6. Tugwell P
    . Community screening for rheumatic disorder: cross cultural adaptation and screening characteristics of the COPCORD Core Questionnaire in Brazil, Chile, and Mexico. The PANLAR-COPCORD Working Group. Pan American League of Associations for Rheumatology. Community Oriented Programme for the Control of Rheumatic Disease. J Rheumatol 1997;24:160–8.
    OpenUrlPubMed
  22. 22.↵
    1. Aletaha D,
    2. Neogi T,
    3. Silman AJ,
    4. Funovits J,
    5. Felson DT,
    6. Bingham CO 3rd,
    7. et al.
    2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580–8.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Massardo L,
    2. Pons-Estel BA,
    3. Wojdyla D,
    4. Cardiel MH,
    5. Galarza-Maldonado CM,
    6. Sacnun MP,
    7. et al.
    Early rheumatoid arthritis in Latin America: low socioeconomic status related to high disease activity at baseline. Arthritis Care Res 2012;64:1135–43.
    OpenUrlPubMed
  24. 24.↵
    1. Sacks JJ,
    2. Harrold LR,
    3. Helmick CG,
    4. Gurwitz JH,
    5. Emani S,
    6. Yood RA
    . Validation of a surveillance case definition for arthritis. J Rheumatol 2005;32:340–7.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Moreno-Montoya J,
    2. Alvarez-Nemegyei J,
    3. Trejo-Valdivia B,
    4. Peláez-Ballestas I;
    5. GEEMA (Grupo de Estudio Epidemiológico de Enfermedades Musculo Articulares)
    . Assessment of the dimensions, construct validity, and utility for rheumatoid arthritis screening of the COPCORD instrument. Clin Rheumatol 2014;33:631–6.
    OpenUrl
  26. 26.↵
    1. Goycochea-Robles MV,
    2. Sanin LH,
    3. Moreno-Montoya J,
    4. Alvarez-Nemegyei J,
    5. Burgos-Vargas R,
    6. Garza-Elizondo M,
    7. et al;
    8. Grupo de Estudio Epidemiológico de Enfermedades Músculo Articulares (GEEMA)
    . Validity of the COPCORD core questionnaire as a classification tool for rheumatic diseases. J Rheumatol 2011;86:31–5.
    OpenUrl
  27. 27.↵
    1. Scublinsky D,
    2. Venarotti H,
    3. Citera G,
    4. Messina OD,
    5. Scheines E,
    6. Rillo O,
    7. et al.
    The prevalence of rheumatoid arthritis in Argentina. A capture-recapture study in a city of Buenos Aires province. J Clin Rheumatol 2010;16:317–21.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Di WT,
    2. Vergara F,
    3. Bertiller E,
    4. Gallardo Mde L,
    5. Gandino I,
    6. Scolnik M,
    7. et al.
    Incidence and prevalence of rheumatoid arthritis in a health management organization in Argentina: a 15-year study. J Rheumatol 2016;43:1306–11.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Cuervo F,
    2. Santos A,
    3. Saldarriaga E,
    4. Angarita I,
    5. Peláez-Ballestas I,
    6. Rueda J,
    7. et al.
    [Prevalence of rheumatic diseases in Colombia]. [Article in Spanish] Medicina 2018;40:94–5.
    OpenUrl
  30. 30.↵
    1. Granados Y,
    2. Cedeño L,
    3. Rosillo C,
    4. Berbin S,
    5. Azocar M,
    6. Molina ME,
    7. et al.
    Prevalence of musculoskeletal disorders and rheumatic diseases in an urban community in Monagas State, Venezuela: a COPCORD study. Clin Rheumatol 2015;34:871–7.
    OpenUrlCrossRef
  31. 31.↵
    1. Gamboa R,
    2. Medina M,
    3. Acevedo E,
    4. Pastor C,
    5. Cucho J,
    6. Gutiérrez C,
    7. et al.
    [Prevalence of rheumatic diseases and disability in a marginal urban community: results of the first COPCORD study in Peru]. [Article in Spanish] Rev Peru Reumatol 2009;15:40–6.
    OpenUrl
  32. 32.↵
    1. Instituto Nacional de Estadisticas Chile
    . [Synthesis from results. Census 2017 Chile]. [Article in Spanish] [Internet. Accessed January 16, 2020.] Available from: www.censo2017.cl/descargas/home/sintesis-de-resultados-censo2017.pdf
  33. 33.↵
    1. Peláez-Ballestas I,
    2. Granados Y,
    3. Quintana R,
    4. Loyola-Sánchez A,
    5. Julián-Santiago F,
    6. Rosillo C,
    7. et al;
    8. Latin American Study Group of Rheumatic Diseases in Indigenous Peoples (GLADERPO)
    . Epidemiology and socioeconomic impact of the rheumatic diseases on indigenous people: an invisible syndemic public health problem. Ann Rheum Dis 2018;77:1397–404.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Bengtsson C,
    2. Nordmark B,
    3. Klareskog L,
    4. Lundberg I,
    5. Alfredsson L;
    6. EIRA Study Group
    . Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2005;64:1588–94.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Verstappen SM
    . The impact of socioeconomic status in rheumatoid arthritis. Rheumatology 2017,56:1051–2.
    OpenUrl
  36. 36.↵
    1. Mackie SL,
    2. Taylor JC,
    3. Twigg S,
    4. Martin SG,
    5. Steer S,
    6. Worthington J,
    7. et al.
    Relationship between area-level socio-economic deprivation and autoantibody status in patients with rheumatoid arthritis: multicentre cross-sectional study. Ann Rheum Dis 2012;71:1640–5.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Di Giuseppe D,
    2. Discacciati A,
    3. Orsini N,
    4. Wolk A
    . Cigarette smoking and risk of rheumatoid arthritis: a dose-response meta-analysis. Arthritis Res Ther 2014;1:R61.
    OpenUrl
  38. 38.↵
    1. Källberg H,
    2. Jacobsen S,
    3. Bengtsson C,
    4. Pedersen M,
    5. Padyukov L,
    6. Garred P,
    7. et al.
    Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies. Ann Rheum Dis 2008;68:222–7.
    OpenUrl
  39. 39.↵
    1. Torres-Quevedo R
    . [Deficit specialists in regions and public system]. [Article in Spanish] Rev Chil Cir 2016;68:279–80.
    OpenUrl
  40. 40.↵
    1. Nell VP,
    2. Machold KP,
    3. Eberl G,
    4. Stamm TA,
    5. Uffmann M,
    6. Smolen JS,
    7. et al.
    Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 2004;43:906–14.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Miltenburger C,
    2. Munkombwe M,
    3. Lekander I
    . A survey of barriers to treatment access in rheumatoid arthritis in major Latin American countries – Argentina, Brazil and Mexico. [Internet. Accessed January 16, 2020.] Available from: www.comparatorreports.se/LA%20RA%20barrier%20report_FINAL.pdf
  42. 42.↵
    1. Ministry of Health
    . [List of GES (Explicit Health Guarantees) benefits]. [Article in Spanish] [Internet. Accessed January 16, 2020.] Available from: diprece.minsal.cl/wrdprss_minsal/wp-content/uploads/2018/03/Lep_incluye-Decreto-8-de-2018.pdf
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section

Keywords

RHEUMATOID ARTHRITIS
ARTHRITIS
PREVALENCE
EPIDEMIOLOGY
SOCIOECONOMIC STATUS
HEALTH SURVEY

Keywords